The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Medical imaging and nuclear medicine: a Lancet Oncology Commission
Open accessAbstract
Executive Summary The diagnosis and treatment of cancer patients requires access to imaging to ensure accurate management decisions and optimal outcomes. Our global assessment of imaging and nuclear medicine resources identified major shortages of equipment and workforce, particularly in low- and middle-income countries (LMIC). A microsimulation model of 11 cancers showed scale-up of imaging would avert 3.2% (2.46 million) of all cancer deaths caused by the modeled cancers between 2020-2030, saving 54.92 million life years. Scale-up of imaging, treatment and care quality would avert 9.55 million (12.5%) of all deaths caused by the modeled cancers, saving 232.30 million life years. Scale-up of imaging would cost $6.84 billion in 2020-2030 but yield global lifetime productivity gains of $1.23 trillion, a net return of $179.19 per $1 invested. Using a conservative human capital approach, scale-up of imaging would provide a net benefit of $209.46 billion and net return of $31.61 per $1 invested. Using the same model and a full income approach, combining scale-up of imaging and treatment and quality of care would provide a net benefit of $2.66 trillion, and a net return of $12.43 per $1 invested. These improved health and economic outcomes were seen across all countries and geographical regions. We propose actions and investment that would enhance access to imaging equipment, workforce capacity, digital technology, radiopharmaceuticals, and research and training programs in LMIC, to realise massive health and economic benefits and reduce the burden of cancer globally.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
U-Net: Convolutional Networks for Biomedical Image Segmentation
Ronneberger, O., Fischer, P., & Brox, T. (2015) · Lecture notes in computer science · doi:10.1007/978-3-319-24574-4_28 · Cited by 99,404
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Radiomics: the bridge between medical imaging and personalized medicine
Lambin, P., Leijenaar, R. T. H., Deist, T. M., Peerlings, J., de Jong, E. E. C., van Timmeren, J., Sanduleanu, S., Larue, R. T. H. M., Even, A. J. G., Jochems, A., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.141 · Cited by 5,688
Brocken, P., van der Heijden, H. F. M., Dekhuijzen, P. N. R., Peters-Bax, L., & de Geus-Oei, L.-F. (2014) · Respiration · doi:10.1159/000347096 · Cited by 4,002
Sources and effects of ionizing radiation
(2018) · United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) Reports · doi:10.18356/f48d655d-en · Cited by 3,985
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607427 · Cited by 3,308
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Bray, F., Jemal, A., Grey, N., Ferlay, J., & Forman, D. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70211-5 · Cited by 2,223
Cited by
Global Burden of Disease 2019 Cancer Collaboration, Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6987 · Cited by 2,026
The Lancet Commission on prostate cancer: planning for the surge in cases
James, N. D., Tannock, I., N'Dow, J., Feng, F., Gillessen, S., Ali, S. A., Trujillo, B., Al-Lazikani, B., Attard, G., Bray, F., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00651-2 · Cited by 738
Fluorescent Probes for Disease Diagnosis
Wang, X., Ding, Q., Groleau, R. R., Wu, L., Mao, Y., Che, F., Kotova, O., Scanlan, E. M., Lewis, S. E., Li, P., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00776 · Cited by 543
The Lancet Commission on diagnostics: transforming access to diagnostics
Fleming, K. A., Horton, S., Wilson, M. L., Atun, R., DeStigter, K., Flanigan, J., Sayed, S., Adam, P., Aguilar, B., Andronikou, S., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00673-5 · Cited by 471
Self-citationRadiotheranostics in oncology: current challenges and emerging opportunities
Bodei, L., Herrmann, K., Schöder, H., Scott, A. M., & Lewis, J. S. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00652-y · Cited by 414
Self-citation
Metadata
- Authors
- Hricak, H., Abdel-Wahab, M., Atun, R., Lette, M. M., Paez, D., Brink, J. A., Donoso-Bach, L., Frija, G., Hierath, M., Holmberg, O., Khong, P.-L., Lewis, J. S., McGinty, G., Oyen, W. J. G., Shulman, L. N., Ward, Z. J., & Scott, A. M.
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 22
- Issue
- 4
- Pages
- e136-e172
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W3135115453
- Cited by
- 368
- References
- 117
- FWCI
- 24.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Medical imaging and nuclear medicine: a Lancet Oncology Commission. https://app.cochat.ai/papers/10.1016/s1470-2045(20)30751-8
- The paper
- Hricak, H., Abdel-Wahab, M., Atun, R., Lette, M. M., Paez, D., Brink, J. A., Donoso-Bach, L., Frija, G., Hierath, M., Holmberg, O., Khong, P.-L., Lewis, J. S., McGinty, G., Oyen, W. J. G., Shulman, L. N., Ward, Z. J., & Scott, A. M. (2021). Medical imaging and nuclear medicine: a Lancet Oncology Commission. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(20)30751-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.